Complete response to pembrolizumab in a patient with dermatomyositis and MMR deficient ovarian cancer: A case report.

Valls, Maia L; Kase, Adam M; Patel, Rina; Wang, Benjamin; Aggarwal, Rohit; Colon-Otero, Gerardo

Valls, Maia L; Kase, Adam M; Patel, Rina; Wang, Benjamin; Aggarwal, Rohit; Colon-Otero, Gerardo.

Afiliação

Valls ML; Ponce Health Sciences University, Ponce, PR.
Kase AM; Division of Hematology/Oncology.
Patel R; Florida Cancer Specialists, Jupiter, FL.
Wang B; Division of Rheumatology Mayo Clinic, Jacksonville, FL.
Aggarwal R; Division of Rheumatology. University of Pittsburgh, Pittsburgh, PA.
Colon-Otero G; Division of Hematology/Oncology.

Gynecol Oncol Rep ; 41: 101010, 2022 Jun.

Article em En | MEDLINE | ID: mdl-35663849

Palavras-chave

Dermatomyositis; MMR deficiency; Microsatellite instability; Ovarian cancer; Pembrolizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Idioma: En Revista: Gynecol Oncol Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Porto Rico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google